August 2024 Update on GeoVax Labs, Inc. (GOVX-NASDAQ) Crystal Research Associates has issued a 17-page Company Update on clinical-stage biotechnology company, ... Karen Goldfarb August 8, 2024 at 10:35 AM
June 2024 Update on GeoVax Labs, Inc. (GOVX-NASDAQ) Crystal Research Associates has issued a 13-page Company Update on clinical-stage biotechnology company, ... Karen Goldfarb June 23, 2024 at 8:38 PM
May 2024 Update on GeoVax Labs, Inc. (GOVX-NASDAQ) Crystal Research Associates has issued a 16-page Quarterly Update on clinical-stage biotechnology company, ... Karen Goldfarb May 15, 2024 at 3:52 PM
New Research on NKore Biotherapeutics, LLC An Executive Informational Overview (EIO) is now available on NKore Biotherapeutics, LLC, a cellular-based ... Karen Goldfarb April 17, 2024 at 11:54 AM
March 2024 Update on GeoVax Labs, Inc. (GOVX-NASDAQ) Crystal Research Associates has issued a 20-page Quarterly Update on clinical-stage biotechnology company, ... Karen Goldfarb March 4, 2024 at 2:00 PM
November 2023 Update on GeoVax Labs, Inc. (GOVX-NASDAQ) Crystal Research Associates has issued an 18-page Quarterly Update on clinical-stage biotechnology company, ... Karen Goldfarb November 10, 2023 at 11:58 AM
August 2023 Update on GeoVax Labs, Inc. (GOVX-NASDAQ) Crystal Research Associates has issued a 20-page Quarterly Update on clinical-stage biotechnology company, ... Karen Goldfarb August 11, 2023 at 2:33 PM
May 2023 Update on GeoVax Labs, Inc. (GOVX-NASDAQ) Crystal Research Associates has issued an 18-page Quarterly Update on clinical-stage biotechnology company, ... Karen Goldfarb May 9, 2023 at 4:48 PM
March 2023 Update on GeoVax Labs, Inc. (GOVX-NASDAQ) Crystal Research Associates has issued a 16-page Quarterly Update on clinical-stage biotechnology company, ... Karen Goldfarb March 28, 2023 at 4:41 PM
New Research Released on CEL-SCI Corporation (CVM-NYSE) An updated Executive Informational Overview (EIO) is now available on CEL-SCI Corporation, a clinical-stage ... Karen Goldfarb March 20, 2023 at 7:13 PM
November 2022 Update on GeoVax Labs, Inc. (GOVX-NASDAQ) Crystal Research Associates has issued a 17-page Quarterly Update on clinical-stage biotechnology company, ... Karen Goldfarb November 11, 2022 at 4:11 PM
August 2022 Update on GeoVax Labs, Inc. (GOVX-NASDAQ) Crystal Research Associates has issued a 19-page Quarterly Update on clinical-stage biotechnology company, ... Karen Goldfarb August 5, 2022 at 4:02 PM
New Research on Genprex, Inc. (GNPX-NASDAQ) An Executive Informational Overview (EIO) is now available on Genprex, Inc., a clinical-stage gene therapy ... Karen Goldfarb June 23, 2022 at 7:58 PM
April 2022 Update on GeoVax Labs, Inc. (GOVX-NASDAQ) Crystal Research Associates has issued a 15-page Quarterly Update on clinical-stage biotechnology company, ... Karen Goldfarb April 29, 2022 at 1:23 PM
March 2022 Update on GeoVax Labs, Inc. (GOVX-NASDAQ) Crystal Research Associates has issued a 15-page Quarterly Update on clinical-stage biotechnology company, ... Karen Goldfarb March 14, 2022 at 6:22 PM